FindTrial
Sign In

Clinical Study on the Effect of "Huoxue Sanfeng" Acupuncture Method on Regulating Average Nocturnal Systolic Blood Pressure in Patients with Primary Hypertension

Observation on the Clinical Efficacy of "Huoxue Sanfeng" Acupuncture Method in Regulating Mean Nocturnal Systolic Blood Pressure in Primary Hypertension Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002480
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-12-18
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary hypertension

Interventions

Acupuncture group:The Huoxue Sanfeng Acupuncture Method combines with basic therapy
Control Group:Sham acupuncturecombined with basic treatment.

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for hypertension and have been regularly taking antihypertensive medication for at least 2 weeks; 2) After the run-in period, confirmed by ambulatory blood pressure monitoring (ABPM) to have abnormal nocturnal systolic blood pressure (defined as an average nocturnal systolic blood pressure =120 mmHg); 3) Age between 18 and 80 years, regardless of gender; 4) All included patients in the study have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Secondary hypertension; 2) Requiring long-term oral beta-blockers, diuretics, or non-dihydropyridine calcium channel blockers (non-DHP CCBs) due to cardiac reasons; 3) Individuals working night shifts or with irregular sleep schedules; 4) Patients with epilepsy or acute cerebrovascular diseases; 5) Patients with severe hematologic diseases, coagulation disorders, or malignant tumors; 6) Patients with diabetic nephropathy, severe hepatic or renal impairment, severe cardiopulmonary insufficiency, or severe arrhythmias; 7) Local skin infection at or near acupuncture points; 8) Pregnant or lactating women; 9) Currently participating in other clinical trials or having participated in other clinical trials within the past month; 10) Inability to continue acupuncture due to adverse local reactions, severe needle phobia, or history of syncope triggered by acupuncture.

Design outcomes

Primary

MeasureTime frame
Average nighttime systolic blood pressure;—

Secondary

MeasureTime frame
average nighttime diastolic blood pressure;average daytime systolic blood pressure;average daytime diastolic pressure;Diurnal pulse rate variability;Nighttime Pulse Rate Variability;9-item Patient Health Questionnaire (PHQ-9);Blood Glucose;blood lipids;Body Mass Index;Life's Crucial 9 (LC-9);—

Countries

China

Contacts

Public ContactFei, Cai

First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

13702030581@163.com13702030581

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026